Physician profile
Brian Dougherty
NPI 1487654299
$2,234.41
in general payments reported to CMS, 2019-2025
15 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $77.20 · 2021: $74.54 · 2022: $353 · 2023: $398 · 2024: $656 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,594.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $993.73 | 2021-2025 | |
| Glaxosmithkline, LLC. | $256.88 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $251.20 | 2019-2025 | Dupixent |
| Optinose US, INC. | $217.97 | 2019-2025 | |
| Aerin Medical INC. | $151.69 | 2024 | |
| Medtronic, INC. | $85.39 | 2024-2025 | Stealthstation S8 Platform, Nuvent |
| Stryker Corporation | $55.30 | 2022 | |
| Integra Lifesciences Corporation | $48.46 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $44.67 | 2023-2024 | Ryaltris |
| Medtronic USA, INC. | $29.25 | 2019 | |
| Ani Pharmaceuticals, INC. | $25.76 | 2025 | Purified Cortrophin Gel |
| Phathom Pharmaceuticals, INC. | $25.59 | 2025 | Voquezna |
| Hologic Sales and Service, LLC | $16.48 | 2023 | Coolseal Generator |
| Aroa Biosurgery Incorporated | $16.32 | 2024 | |
| Lilly USA, LLC | $15.72 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.